Nanobiotix
 | |
| Euronext: NANO | |
| Industry | Biotechnology |
| Founded | 2003 |
| Headquarters | Paris, France |
Key people | Laurent Levy ( CEO) |
| Products | NBTXR3 (Hensify®) |
| €2.54 million (2019) | |
| Total assets | €54.9 million (2019) |
Number of employees | 110 (2020) |
| Website | www.nanobiotix.com |
Nanobiotix is a biotechnology company. It uses nanomedicine to develop new radiotherapy techniques for cancer patients. The home office of the company is in Paris. Also, it has offices in New York and Massachusetts.
Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
